These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 15247

  • 21. Pyruvate kinase deficiency: characterization of two new genetic variants.
    Dente L, D'Urso M, Di Maio S, Brancaccio V, Luzzatto L.
    Clin Chim Acta; 1982 Dec 09; 126(2):143-54. PubMed ID: 7151276
    [Abstract] [Full Text] [Related]

  • 22. Phosphorylation of pyruvate kinase type K is restricted to the dimeric form.
    Weernink PA, Rijksen G, Mascini EM, Staal GE.
    Biochim Biophys Acta; 1992 May 22; 1121(1-2):61-8. PubMed ID: 1599952
    [Abstract] [Full Text] [Related]

  • 23. Pyruvate kinase Greensboro. A four-generation study of a high K0.5s (phosphoenolpyruvate) variant.
    Valentine WN, Herring WB, Paglia DE, Steuterman MC, Brockway RA, Nakatani M.
    Blood; 1988 Sep 22; 72(3):1054-9. PubMed ID: 3416067
    [Abstract] [Full Text] [Related]

  • 24. Purification and properties of pyruvate kinase from Streptococcus lactis.
    Crow VL, Pritchard GG.
    Biochim Biophys Acta; 1976 Jun 07; 438(1):90-101. PubMed ID: 820379
    [Abstract] [Full Text] [Related]

  • 25. A new variant of red blood cell pyruvate kinase deficiency.
    Staal GJ, Koster JF, Nijessen JG.
    Biochim Biophys Acta; 1972 Feb 28; 258(2):685-7. PubMed ID: 5010308
    [No Abstract] [Full Text] [Related]

  • 26. Hysteretic response of human erythrocyte pyruvate kinase to phosphoenolpyruvate. Potential role in regulation of 2,3-bisphosphoglycerate metabolism.
    Badwey JA, Westhead EW.
    J Biol Chem; 1976 Sep 25; 251(18):5600-6. PubMed ID: 965380
    [Abstract] [Full Text] [Related]

  • 27. [Significance of kinetic abnormalities of erythrocyte pyruvate kinase in congenital deficiencies].
    Boivin P, Galand C.
    Pathol Biol (Paris); 1977 Mar 25; 25(3):161-7. PubMed ID: 323784
    [Abstract] [Full Text] [Related]

  • 28. Purification and kinetic properties of pyruvate kinase from Brochothrix thermosphacta.
    Singh SP, Rogers PJ.
    Biochem Int; 1991 Sep 25; 25(1):35-45. PubMed ID: 1772447
    [Abstract] [Full Text] [Related]

  • 29. Stabilization of different conformational states of liver pyruvate kinase type L by the allosteric activators.
    Rozengurt E, Jimenez de Asua L, Carminatti H.
    FEBS Lett; 1973 Dec 01; 37(2):225-7. PubMed ID: 4763324
    [No Abstract] [Full Text] [Related]

  • 30. The regulatory properties of yeast pyruvate kinase. Effect of pH.
    Kinderlerer J, Ainsworth S, Morris CN, Rhodes N.
    Biochem J; 1986 Mar 15; 234(3):699-703. PubMed ID: 3521596
    [Abstract] [Full Text] [Related]

  • 31. Comparative kinetic and electrophoretic properties of erythrocyte pyruvate kinases.
    Beeson MA, Black JA.
    Comp Biochem Physiol B; 1976 Mar 15; 53(4):489-93. PubMed ID: 816594
    [No Abstract] [Full Text] [Related]

  • 32. Application of the metal complex concept to enzyme reactions.
    Cumme GA, Horn A, Bublitz R, Achilles W.
    Acta Biol Med Ger; 1973 Mar 15; 31(6):771-80. PubMed ID: 4791174
    [No Abstract] [Full Text] [Related]

  • 33. Difference in pyruvate kinase regulation among three groups of yeasts.
    Hirai M, Tanaka A, Fukui S.
    Biochim Biophys Acta; 1975 Jun 24; 391(2):282-91. PubMed ID: 1096944
    [Abstract] [Full Text] [Related]

  • 34. Purification of a Ca2+-activated protease from rat erythrocytes and its possible effect on pyruvate kinase in vivo.
    Dahlqvist-Edberg U, Ekman P.
    Biochim Biophys Acta; 1981 Jul 24; 660(1):96-101. PubMed ID: 6268175
    [Abstract] [Full Text] [Related]

  • 35. Adrenergic regulation of Rana balcanica erythrocyte pyruvate kinase.
    Kaloyianni M, Cotoglou C, Giagtzoglou N.
    J Comp Physiol B; 2000 Mar 24; 170(2):85-90. PubMed ID: 10791568
    [Abstract] [Full Text] [Related]

  • 36. Ligand-induced conformational changes in wild-type and mutant yeast pyruvate kinase.
    Collins RA, Kelly SM, Price NC, Fothergill-Gilmore LA, Muirhead H.
    Protein Eng; 1996 Dec 24; 9(12):1203-10. PubMed ID: 9010934
    [Abstract] [Full Text] [Related]

  • 37. Defective erythrocyte pyruvate kinase.
    Staal GE, Ceerdink RP, Vlug AM, Hamelink ML.
    Clin Chim Acta; 1976 Apr 01; 68(1):11-5. PubMed ID: 1261049
    [Abstract] [Full Text] [Related]

  • 38. A Spanish family with erythrocyte pyruvate kinase deficiency: contribution of various immunologic methods in the study of the mutant enzyme.
    Kahn A, Vives-Corron JL, Marie J, Galand C, Boivin P.
    Clin Chim Acta; 1977 Feb 15; 75(1):71-8. PubMed ID: 403035
    [Abstract] [Full Text] [Related]

  • 39. Influence of the rebox state of glutathione upon pyruvate kinase in the intact erythrocyte.
    Sprengers ED, van Berkel TJ, Koster JF, Staal GE.
    Clin Chim Acta; 1977 Nov 01; 80(3):495-502. PubMed ID: 912917
    [Abstract] [Full Text] [Related]

  • 40. The regulatory properties of yeast pyruvate kinase. Effects of NH4+ and K+ concentrations.
    Rhodes N, Morris CN, Ainsworth S, Kinderlerer J.
    Biochem J; 1986 Mar 15; 234(3):705-15. PubMed ID: 3521597
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.